Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Cyclerion Therapeutics
(NASDAQ:CYCN)
Intraday
$2.96
-0.09
[-2.95%]
After-Hours
$2.96
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$2.96
-0.09
[-2.95%]
At close: Apr 18
$2.96
0
[0.00%]
After Hours: 8:26AM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Cyclerion Therapeutics Stock (NASDAQ:CYCN)
Cyclerion Therapeutics Stock (NASDAQ: CYCN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, February 06, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Feb 6, 2024, 12:31PM
Thursday, January 11, 2024
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
-
Jan 11, 2024, 12:31PM
Monday, December 04, 2023
Cyclerion Therapeutics Announced That Regina Graul Has Joined The Company As President, Effective Immediately, Peter Hecht Will Continue To Work As A Strategic Consultant And Board Member; Steps Down From CEO Role
Benzinga Newsdesk
-
Dec 4, 2023, 8:11AM
Friday, December 01, 2023
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Dec 1, 2023, 12:31PM
Why Genesco Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
-
Dec 1, 2023, 12:04PM
Tuesday, October 10, 2023
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Oct 10, 2023, 1:31PM
Thursday, July 27, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
Jul 27, 2023, 12:17PM
Wednesday, July 26, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
Jul 26, 2023, 12:18PM
Tuesday, July 25, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Jul 25, 2023, 12:33PM
Thursday, June 01, 2023
Cyclerion Regains Compliance With Nasdaq Minimum Bid Price Requirement
Benzinga Newsdesk
-
Jun 1, 2023, 4:01PM
Tuesday, May 23, 2023
Chief Executive Officer of Cyclerion Therapeutics Makes $1.95M Buy
Benzinga Insights
-
May 23, 2023, 11:05AM
Tuesday, May 16, 2023
Shares of Cyclerion Therapeutics are trading higher on above-average volume. Not seeing any company-specific news to justify the price action.
Benzinga Newsdesk
-
May 16, 2023, 3:47PM
Why RH Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
-
May 16, 2023, 1:13PM
Monday, May 15, 2023
Cyclerion Reports 1-For-20 Reverse Stock Split, Effective 5 p.m. On May 15
Benzinga Newsdesk
-
May 15, 2023, 1:03PM
Friday, May 12, 2023
Cyclerion Therapeutics to Sell Assets for $81M, CEO Transition To New Spin-Off Private Company Established By Shareholders, New Investors
Vandana Singh
-
May 12, 2023, 12:59PM
Thursday, May 11, 2023
Cyclerion Therapeutics Reports Q1 Net Loss Of $(7.0)M Vs $(13.0)M Last Year
Benzinga Newsdesk
-
May 11, 2023, 6:07PM
Cyclerion Inks Definitive Agreement For Zagociguat And CY3018
Benzinga Newsdesk
-
May 11, 2023, 6:03PM
Wednesday, April 26, 2023
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Apr 26, 2023, 9:06AM
Wednesday, April 05, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
Apr 5, 2023, 2:28PM
Monday, April 03, 2023
Cyclerion Therapeutics Says Board Has Reviewed Non-Binding Proposal From Entity Formed By Investors Including Co.'s CEO To Purchase Zagociguat And CY3018 Assets; Says Board Has Concluded Proposal Merits Further Pursuit
Benzinga Newsdesk
-
Apr 3, 2023, 7:37AM
Monday, March 27, 2023
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
-
Mar 27, 2023, 1:31PM
Why Jounce Therapeutics Shares Are Trading Higher By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
-
Mar 27, 2023, 1:22PM
Cyclerion Therapeutics shares are trading higher after the company announced it received FDA orphan drug designation for zagociguat for the treatment of mitochondrial diseases.
Benzinga Newsdesk
-
Mar 27, 2023, 10:40AM
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Mar 27, 2023, 9:06AM
Cyclerion Therapeutics Gets US FDA Orphan Drug Designation For Zagociguat For Treatment Of Mitochondrial Diseases
Benzinga Newsdesk
-
Mar 27, 2023, 7:24AM
Thursday, March 23, 2023
Cyclerion Therapeutics Gets FDA Orphan Drug Designation For Zagociguat For Treatment Of Mitochondrial Disease
Happy Mohamed
-
Mar 23, 2023, 3:47PM
Wednesday, March 22, 2023
Cyclerion Reports Corporate Update And FY22 Financial Results; Cash, Cash Equivalents, And Restricted Cash Balance On December 31, 2022 Was ~$13.4M
Happy Mohamed
-
Mar 22, 2023, 4:47PM
Thursday, February 02, 2023
Cyclerion Therapeutics Receives Notice Of Allowance For Patent Application Titled "NOVEL PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF SOLUBLE GUANYLATE CYCLASE STIMULATORS".
Benzinga Newsdesk
-
Feb 2, 2023, 3:36PM
Wednesday, November 23, 2022
Why American Eagle Outfitters Shares Climbed Over 18%; Here Are 78 Biggest Movers From Yesterday
Lisa Levin
-
Nov 23, 2022, 5:25AM
Tuesday, November 22, 2022
Why Dollar Tree Shares Are Trading Lower By 10%? Here Are 53 Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
-
Nov 22, 2022, 1:16PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Nov 22, 2022, 12:31PM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
-
Nov 22, 2022, 8:08AM
Cyclerion Says Concluded The Unsolicited Proposal Received On Nov. 20 Was 'Not in The Best Interest of The Company'
Bill Haddad
-
Nov 22, 2022, 7:10AM
Why ObsEva Shares Are Trading Higher By Over 70%; Here Are 21 Stocks Moving Premarket
Lisa Levin
-
Nov 22, 2022, 6:22AM
Friday, October 28, 2022
Why Meta Platforms Shares Dipped Around 25%; Here Are 77 Biggest Movers From Yesterday
Lisa Levin
-
Oct 28, 2022, 4:57AM
Tuesday, October 25, 2022
Why Tricida Shares Dipped Around 95%; Here Are 73 Biggest Movers From Yesterday
Lisa Levin
-
Oct 25, 2022, 5:55AM
Monday, October 24, 2022
Why Vaxcyte Shares Are Trading Sharply Higher? Here Are 63 Stocks Moving In Monday's Mid-Day Session
Lisa Levin
-
Oct 24, 2022, 12:30PM
Monday, October 17, 2022
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Oct 17, 2022, 5:51PM
Tuesday, October 11, 2022
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Oct 11, 2022, 2:10PM
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Oct 11, 2022, 12:47PM
Monday, October 10, 2022
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
-
Oct 10, 2022, 2:12PM
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
-
Oct 10, 2022, 12:29PM
Friday, October 07, 2022
Why Avenue Therapeutics Is Trading Lower By 59%; Here Are 31 Stocks Moving Premarket
Lisa Levin
-
Oct 7, 2022, 7:49AM
Why Cyclerion Therapeutics Shares Traded Lower By Around 38%; Here Are 70 Biggest Movers From Yesterday
Lisa Levin
-
Oct 7, 2022, 6:29AM
Thursday, October 06, 2022
Dow Dips Over 300 Points; Provention Bio Shares Spike Higher
Lisa Levin
-
Oct 6, 2022, 2:51PM
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
-
Oct 6, 2022, 2:42PM
Cyclerion Shares Fall After Reprioritized Pipeline, Workforce Reduction
Vandana Singh
-
Oct 6, 2022, 12:46PM
Why Revelation Biosciences Shares Are Trading Higher By 29%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
-
Oct 6, 2022, 12:41PM
Why Cyclerion Therapeutics Stock Is Getting Hammered
Henry Khederian
-
Oct 6, 2022, 12:13PM
Nasdaq Edges Higher; AngioDynamics Shares Plummet
Lisa Levin
-
Oct 6, 2022, 12:05PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch